Wealthcare Capital Management LLC Eli Lilly & CO Transaction History

Wealthcare Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$724.87 - $909.04 $169,619 - $212,715	234 New	234 $211,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $29,068 - $37,599	-161 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $26,455 - $34,247	161 New	161 $30,000
Q2 2020 Jul 29, 2020	SELL	$136.42 - $164.18 $272 - $328	-2 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$119.05 - $147.35 $6,904 - $8,546	-58 Reduced 96.67%	2 $0
Q4 2019 Jan 29, 2020	BUY	$106.92 - $132.43 $6,415 - $7,945	60 New	60 $8,000

4,011

751M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Wealthcare Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Capital Management LLC with notifications on news.